Lymphocyte clue to MS drug,Alemtuzumab response

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Lymphocyte clue to MS drug,Alemtuzumab response

Postby MSUK » Tue Dec 18, 2012 11:24 pm

Image

Patients with rapid recovery of CD4-positive T cells after alemtuzumab treatment for multiple sclerosis (MS) are at risk for disease progression or relapse, research suggests.

The difference was apparent from 3 months after treatment, implying the potential for individualized treatment protocols based on CD4+ counts, say lead researcher Neil Robertson (Cardiff University, UK) and colleagues.

"The association between disease activity and early lymphocyte recovery is not surprising, as MS is primarily a cell-mediated disorder," they write in Neurology. "However, this relationship has not been demonstrated in vivo before."

The researchers assessed 56 patients (40 women) given alemtuzumab 12 mg daily for 5 days to treat symptoms of MS. They observed an initial "profound depletion" of lymphocyte subsets, followed by gradual recovery.

CD19+ cells were the first to recover, reaching the 25th percentile of average pretreatment levels at 3-6 months after treatment. These were followed by CD8+ cells, which reached a similar level after 6-9 months....Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1307
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2188
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: sophie447


Contact us | Terms of Service